東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Modification of tumor micro-environm...

Wu, Chao-Yi Joy.

Linked to FindBook

Google Book

Amazon

博客來

Modification of tumor micro-environment to enhance anti-tumor immune response.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Modification of tumor micro-environment to enhance anti-tumor immune response./
Author:	Wu, Chao-Yi Joy.
Description:	156 p.
Notes:	Source: Dissertation Abstracts International, Volume: 74-12(E), Section: B.
Contained By:	Dissertation Abstracts International74-12B(E).
Subject:	Health Sciences, Immunology. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3573107
ISBN:	9781303422805

Modification of tumor micro-environment to enhance anti-tumor immune response.
Wu, Chao-Yi Joy.

Modification of tumor micro-environment to enhance anti-tumor immune response. - 156 p.

Source: Dissertation Abstracts International, Volume: 74-12(E), Section: B.

Thesis (Ph.D.)--The Johns Hopkins University, 2013.

Increasing attention have been generated to minimized the adverse immune impact of tumor infiltrated myeloid cells to increase the anti-tumor immune response and potentially enhance tumor control. In present study, we've demonstrated that intratumorally administration of a peptide based vaccine in well defined solid tumor combining PADRE peptide and poly I:C leads to an enhanced antitumor effects in treated mice comparing with conventional vaccine route giving subcutaneous (Chapter 2). This challenges the prevailing notion of the tumor as an inherently immune-suppressive site and underscores the dynamic nature of interactions between the tumor and the immune system. Also, we evaluate the phenotype change of macrophages in the peritoneal cavity of disseminated ovarian cancer model after poly I:C treatment. With the help of PEI to increase the uptake of poly I:C by the peritoneal cells, significant improvement was observed in the antitumor effects against murine ovarian tumors. This anti-tumor effect was contributed by the alternative MI activation of peritoneal macrophages when treated and sequentially activate NK cells to clear tumor (Chapter 3). This suggests that the environment of ill-define disseminated tumors can also be changed to significantly benefit tumor control. Last, we focus on how conventional cancer treatments, tumor irradiation impact the tumor microenvironment. In chapter 4, we've show that by combining RT and targeted delivery of antigenic peptide to the tumor, the adjuvant effect generated by RT itself is sufficient to elicit the priming and expansion of antigen-specific CD8+ T cells through the type 1 interferon and toll like receptor 4 dependent pathways and leads to a potent therapeutic antitumor effect. In addition, we demonstrated that CTL-mediated killing of CD11b+ myeloid stromal cells, in the tumor by our approach is important for the control of tumor growth using two different transgenic mouse models. Altogether, we observed a greater tumor control achieved through the suppression of the immunomodulatory effects and the enhancement of favorable immune stimulation due to local RT. In summary, these results demonstrate that the immune-suppressive tumor micro-environment can be reversed by available, commonly practiced, interventions and provide impetus for the development and clinical translation of novel immune-based strategies for cancer therapy.

ISBN: 9781303422805Subjects--Topical Terms:

1017716
Health Sciences, Immunology.

Modification of tumor micro-environment to enhance anti-tumor immune response.
LDR:03332nam a2200289 4500 001 1966815
005 20141112075114.5
008 150210s2013 ||||||||||||||||| ||eng d
020 $a 9781303422805
035 $a (MiAaPQ)AAI3573107
035 $a AAI3573107
040 $a MiAaPQ $c MiAaPQ
100 1 $a Wu, Chao-Yi Joy. $3 2103695
245 1 0 $a Modification of tumor micro-environment to enhance anti-tumor immune response.
300 $a 156 p.
500 $a Source: Dissertation Abstracts International, Volume: 74-12(E), Section: B.
500 $a Advisers: T.-C. Wu; Richard B. S. Roden.
502 $a Thesis (Ph.D.)--The Johns Hopkins University, 2013.
520 $a Increasing attention have been generated to minimized the adverse immune impact of tumor infiltrated myeloid cells to increase the anti-tumor immune response and potentially enhance tumor control. In present study, we've demonstrated that intratumorally administration of a peptide based vaccine in well defined solid tumor combining PADRE peptide and poly I:C leads to an enhanced antitumor effects in treated mice comparing with conventional vaccine route giving subcutaneous (Chapter 2). This challenges the prevailing notion of the tumor as an inherently immune-suppressive site and underscores the dynamic nature of interactions between the tumor and the immune system. Also, we evaluate the phenotype change of macrophages in the peritoneal cavity of disseminated ovarian cancer model after poly I:C treatment. With the help of PEI to increase the uptake of poly I:C by the peritoneal cells, significant improvement was observed in the antitumor effects against murine ovarian tumors. This anti-tumor effect was contributed by the alternative MI activation of peritoneal macrophages when treated and sequentially activate NK cells to clear tumor (Chapter 3). This suggests that the environment of ill-define disseminated tumors can also be changed to significantly benefit tumor control. Last, we focus on how conventional cancer treatments, tumor irradiation impact the tumor microenvironment. In chapter 4, we've show that by combining RT and targeted delivery of antigenic peptide to the tumor, the adjuvant effect generated by RT itself is sufficient to elicit the priming and expansion of antigen-specific CD8+ T cells through the type 1 interferon and toll like receptor 4 dependent pathways and leads to a potent therapeutic antitumor effect. In addition, we demonstrated that CTL-mediated killing of CD11b+ myeloid stromal cells, in the tumor by our approach is important for the control of tumor growth using two different transgenic mouse models. Altogether, we observed a greater tumor control achieved through the suppression of the immunomodulatory effects and the enhancement of favorable immune stimulation due to local RT. In summary, these results demonstrate that the immune-suppressive tumor micro-environment can be reversed by available, commonly practiced, interventions and provide impetus for the development and clinical translation of novel immune-based strategies for cancer therapy.
520 $a iii.
590 $a School code: 0098.
650 4 $a Health Sciences, Immunology. $3 1017716
650 4 $a Health Sciences, Oncology. $3 1018566
690 $a 0982
690 $a 0992
710 2 $a The Johns Hopkins University. $3 1017431
773 0 $t Dissertation Abstracts International $g 74-12B(E).
790 $a 0098
791 $a Ph.D.
792 $a 2013
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3573107